1. Marino AM, Arua E, de Vos L, Fiphaza K, et al.
   Hidden in Success: Gendered Patterns of Suboptimal Care Engagement Among TB Patients Who "Successfully" Completed Treatment in South Africa.
   Clin Infect Dis 2025.
   


2. Calderin JM, Resendiz-Galvan JE, Abdelgawad N, Davis A, et al.
   Pharmacokinetics of Dexamethasone in Tuberculous Meningitis.
   Clin Infect Dis 2025.
   


3. Te Linde E, Wit FWNM, van Welzen BJ, Goorhuis A, et al.
   Incidence of community-acquired pneumonia and herpes zoster in people with HIV based on CD4-count and age in the current antiretroviral therapy era: a longitudinal cohort study.
   Clin Infect Dis 2025.
   


4. Zhu W, Patel RR, Delaney KP, Huang YA, et al.
   Simplifying testing for HIV during PrEP Monitoring.
   Clin Infect Dis 2025.
   


5. Spinelli MA, Scott HM, Buchbinder SP.
   The Urgency of Now: Congenital Syphilis in the Doxy-PEP Era.
   Clin Infect Dis 2025.
   


6. Zhu W, Bessler P, Lale A, Delaney K, et al.
   Real-World Positive Predictive Value and False Positive Rates of Laboratory-Based HIV Antigen/Antibody Testing by Age and Sex - United States, 2019-2024.
   J Acquir Immune Defic Syndr 2025.
   


7. Byanova KL, Fitzpatrick J, Zawedde J, Byanyima P, et al.
   Predictors of Abnormal Diffusing Capacity for Carbon Monoxide in Post-Pneumonia Ugandans with and without HIV.
   J Acquir Immune Defic Syndr 2025.
   


8. Griffin D, Vaz K, Basu G, Mulley W, et al.
   Knowledge and Attitudes about Solid Organ Transplantation for People with HIV in Australia: A Cross-sectional Survey of People with and without HIV.
   J Acquir Immune Defic Syndr 2025.
   


9. Zhou Y, Lau B, Rudolph JE, Zhang X, et al.
   Incidence of AIDS-defining Illness by Cancer Status in an Observational Study among Medicaid Beneficiaries Living with HIV in the United States, 2001 - 2015.
   J Acquir Immune Defic Syndr 2025.
   


10. van Wees DA, Sarink D, van Benthem BHB, Kampman K, et al.
    Lost and not found: Determinants and patterns of loss to follow-up among men who have sex with men in the Dutch HIV pre-exposure prophylaxis pilot program.
    J Acquir Immune Defic Syndr 2025.
    


11. Diamond TL, Kapoor Y, Li F, Wan BL, et al.
    Weekly Oral Prophylaxis With MK-8527 Protects Rhesus Macaques From Intrarectal Challenge With Simian-Human Immunodeficiency Virus.
    J Infect Dis 2025.
    


12. Chowdhury A, Garcia BG, Zahoor MA, Fadl ElMawla N, et al.
    A rapid assay for HCV RNA detection using RT-LAMP coupled CRISPR-Cas12b based strategy.
    J Infect Dis 2025.
    


13. Ofotokun I, Titanji K, Dabeer S, Tripathi AK, et al.
    IL-4 Correlates With Bone Mineral Density in Men, and IL-4 Depletion May Drive Bone Loss in Men With HIV.
    J Infect Dis 2025.
    


14. Luckey A, Balasegaram M, Barbee LA, Batteiger TA, et al.
    Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial.
    Lancet 2025.
    


15. Meya DB, Cresswell FV, Dai B, Engen N, et al.
    Trial of High-Dose Oral Rifampin in Adults with Tuberculous Meningitis.
    N Engl J Med 2025;393:2434-2446.
    


16. Totapally M, Meyer K, Totapally BR.
    The Prevalence and Trend of Nontuberculous Mycobacterial Infection in Hospitalized Children in the United States From 2000 to 2022.
    Pediatr Infect Dis J 2025.
    


17. Qian J, Lubkowska L, Zhang S, Tan C, et al.
    Chromatin buffers torsional stress during transcription.
    Science 2025.
    

Display articles in

• Abstract format